MedPath

Effect of nonsurgical periodontal therapy on gingival crevicular fluid level of Cathepsin K in chronic periodontitis patients with type 2 diabetes mellitus

Not Applicable
Completed
Conditions
periodontitis diabetes
Cathepsin K
Diabetes mellitus
periodontal therapy
Registration Number
TCTR20170424002
Lead Sponsor
n/a
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
28
Inclusion Criteria

1. Type II Diabetic patients were diagnosed from Internal medicine physician in Internal medicine of Golden Jubilee Medical Center, Mahidol university, based on diagnosis and classification of American Diabetes Association.Patients who have HbA1c more than 7% were included.

2.Non-diabetic patients without family history of diabetes mellitus by history taking of signs&symptoms and risk factors (The expert committee on the diagnosis and classification of diabetes), medical records review and fasting blood sugar screening.

3. Periodontic patients were diagnosed base on the classification system of American Academy of Periodontology.Patients who have clicnical attachment level more than 3 mm. in 30% were included.

Exclusion Criteria

- Patients have bone disease and periodontitis as a manifestation of ystemic disease such as arthritis, osteoporosis, smoking and pregnancy.
- Patients were on medications such as antibiotics, steroids, Bisphosphonates, calciums, vitamin D and hormone replacement therapy within 6 months.
- Patients were treated periodontal disease within 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean change of Cathepsin K level Before and after initial therapy ELISA test
Secondary Outcome Measures
NameTimeMethod
Correlation between HbA1C level and Cathepsin K level Before and after initial therapy statistical analysis
© Copyright 2025. All Rights Reserved by MedPath